GI Partners, a private investment firm, has completed the previously announced acquisition of Clinical Ink Inc., a global clinical trial technology company.   Headquartered in Horsham, PA, Clinical Ink offers data certainty from source to submission during clinical trials. The company’s Lumenis eSource clinical technology is a suite of solutions for capturing and integrating clinical trial electronic study data from sites, clinicians, and patients in real time. Through configurable direct data c...